다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
BMC biotechnology, v.8, 2008년, pp.61 - 61
Goh, Shan (Department of Cell and Molecular Biology, Karolinska Institute, Stockholm, SE-17177, Sweden) , Good, Liam (Department of Cell and Molecular Biology, Karolinska Institute, Stockholm, SE-17177, Sweden)
AI-Helper
BackgroundAntibiotic resistance genes are widely used for selection of recombinant bacteria, but their use risks contributing to the spread of antibiotic resistance. In particular, the practice is inappropriate for some intrinsically resistant bacteria and in vaccine production, and costly for indus...
Points to consider in the production and testing of new drugs and biologicals produced by recombinant DNA technology
Validation of growth-based rapid microbiological methods for sterility testing of cellular and gene therapy products
Titball RW Sjostedt A Pavelka MS Jr Nano FE Biosafety and selectable markers Ann N Y Acad Sci 2007 1105 405 417 17416926 10.1196/annals.1409.002
Fajardo A Martinez-Martin N Mercadillo M Galan JC Ghysels B Matthijs S Cornelis P Wiehlmann L Tummler B Baquero F Martinez JL The neglected intrinsic resistome of bacterial pathogens PLoS ONE 2008 3 e1619 18286176 10.1371/journal.pone.0001619
Gonzalez A Davila G Calva E Cloning of a DNA sequence that complements glutamine auxotrophy in Saccharomyces cerevisiae Gene 1985 36 123 129 2866146 10.1016/0378-1119(85)90076-9
Cranenburgh RM Hanak JA Williams SG Sherratt DJ Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration Nucleic Acids Res 2001 29 E26 11222777 10.1093/nar/29.5.e26
Dryselius R Nekhotiaeva N Nielsen PE Good L Antibiotic-free bacterial strain selection using antisense peptide nucleic acid Biotechniques 2003 35 1060 1064 14628680
Mairhofer J Pfaffenzeller I Merz D Grabherr R A novel antibiotic free plasmid selection system: advances in safe and efficient DNA therapy Biotechnol J 2008 3 83 89 17806101 10.1002/biot.200700141
Xu HH Real L Bailey MW An array of Escherichia coli clones over-expressing essential proteins: a new strategy of identifying cellular targets of potent antibacterial compounds Biochem Biophys Res Commun 2006 349 1250 1257 16978582 10.1016/j.bbrc.2006.08.166
Bergler H Wallner P Ebeling A Leitinger B Fuchsbichler S Aschauer H Kollenz G Hogenauer G Turnowsky F Protein EnvM is the NADH-dependent enoyl-ACP reductase (FabI) of Escherichia coli J Biol Chem 1994 269 5493 5496 8119879
Heath RJ Yu YT Shapiro MA Olson E Rock CO Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis J Biol Chem 1998 273 30316 30320 9804793 10.1074/jbc.273.46.30316
McMurry LM Oethinger M Levy SB Triclosan targets lipid synthesis Nature 1998 394 531 532 9707111 10.1038/28970
Heath RJ Rubin JR Holland DR Zhang E Snow ME Rock CO Mechanism of triclosan inhibition of bacterial fatty acid synthesis J Biol Chem 1999 274 11110 11114 10196195 10.1074/jbc.274.16.11110
Russell AD Biocide use and antibiotic resistance: the relevance of laboratory findings to clinical and environmental situations Lancet Infect Dis 2003 3 794 803 14652205 10.1016/S1473-3099(03)00833-8
Panagakos FS Volpe AR Petrone ME DeVizio W Davies RM Proskin HM Advanced oral antibacterial/anti-inflammatory technology: A comprehensive review of the clinical benefits of a triclosan/copolymer/fluoride dentifrice J Clin Dent 2005 16 S1 19 16583598
Wohlrab J Jost G Abeck D Antiseptic efficacy of a low-dosed topical triclosan/chlorhexidine combination therapy in atopic dermatitis Skin Pharmacol Physiol 2007 20 71 76 17143011 10.1159/000097653
Aiello AE Larson E Antibacterial cleaning and hygiene products as an emerging risk factor for antibiotic resistance in the community Lancet Infect Dis 2003 3 501 506 12901892 10.1016/S1473-3099(03)00723-0
Chuanchuen R Beinlich K Hoang TT Becher A Karkhoff-Schweizer RR Schweizer HP Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ Antimicrob Agents Chemother 2001 45 428 432 11158736 10.1128/AAC.45.2.428-432.2001
Braoudaki M Hilton AC Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents J Clin Microbiol 2004 42 73 78 14715734 10.1128/JCM.42.1.73-78.2004
Karatzas KA Webber MA Jorgensen F Woodward MJ Piddock LJ Humphrey TJ Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasiveness J Antimicrob Chemother 2007 60 947 955 17855722 10.1093/jac/dkm314
Cole EC Addison RM Rubino JR Leese KE Dulaney PD Newell MS Wilkins J Gaber DJ Wineinger T Criger DA Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers J Appl Microbiol 2003 95 664 676 12969278 10.1046/j.1365-2672.2003.02022.x
McBain AJ Bartolo RG Catrenich CE Charbonneau D Ledder RG Price BB Gilbert P Exposure of sink drain microcosms to triclosan: population dynamics and antimicrobial susceptibility Appl Environ Microbiol 2003 69 5433 5442 12957932 10.1128/AEM.69.9.5433-5442.2003
Beier RC Duke SE Ziprin RL Harvey RB Hume ME Poole TL Scott HM Highfield LD Alali WQ Andrews K Antibiotic and Disinfectant Susceptibility Profiles of Vancomycin-Resistant Enterococcus faecium (VRE) Isolated from Community Wastewater in Texas Bull Environ Contam Toxicol 2008
Opinion on triclosan resistance
Drug approvals
Lee C Kim J Shin SG Hwang S Absolute and relative QPCR quantification of plasmid copy number in Escherichia coli J Biotechnol 2006 123 273 280 16388869 10.1016/j.jbiotec.2005.11.014
Livak KJ Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 2001 25 402 408 11846609 10.1006/meth.2001.1262
Nilsson AI Zorzet A Kanth A Dahlstrom S Berg OG Andersson DI Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genes Proc Natl Acad Sci USA 2006 103 6976 6981 16636273 10.1073/pnas.0602171103
Roth BL Poot M Yue ST Millard PJ Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain Appl Environ Microbiol 1997 63 2421 2431 9172364
Lenski RE Simpson SC Nguyen TT Genetic analysis of a plasmid-encoded, host genotype-specific enhancement of bacterial fitness J Bacteriol 1994 176 3140 3147 8195066
Guzman LM Belin D Carson MJ Beckwith J Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter J Bacteriol 1995 177 4121 4130 7608087
Heath RJ Rock CO Regulation of fatty acid elongation and initiation by acyl-acyl carrier protein in Escherichia coli J Biol Chem 1996 271 1833 1836 8567624 10.1074/jbc.271.4.1833
Ward WH Holdgate GA Rowsell S McLean EG Pauptit RA Clayton E Nichols WW Colls JG Minshull CA Jude DA Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan Biochemistry 1999 38 12514 12525 10493822 10.1021/bi9907779
Weitao T Nordstrom K Dasgupta S Mutual suppression of mukB and seqA phenotypes might arise from their opposing influences on the Escherichia coli nucleoid structure Mol Microbiol 1999 34 157 168 10540294 10.1046/j.1365-2958.1999.01589.x
Yue TF Dayton PG Gutman AB Mutual Suppression of the Uricosuric Effects of Sulfinpyrazone and Salicylate: a Study in Interactions between Drugs J Clin Invest 1963 42 1330 1339 14060403 10.1172/JCI104817
Wild DG Reversion from erythromycin dependence in Escherichia coli : strains altered in ribosomal sub-unit association and ribosome assembly J Gen Microbiol 1988 134 1251 1263 2462010
Goldstein F Perutka J Cuirolo A Plata K Faccone D Morris J Sournia A Kitzis MD Ly A Archer G Rosato AE Identification and phenotypic characterization of a beta-lactam-dependent, methicillin-resistant Staphylococcus aureus strain Antimicrob Agents Chemother 2007 51 2514 2522 17470657 10.1128/AAC.00040-07
Van Bambeke F Chauvel M Reynolds PE Fraimow HS Courvalin P Vancomycin-dependent Enterococcus faecalis clinical isolates and revertant mutants Antimicrob Agents Chemother 1999 43 41 47 9869563
Aiello AE Marshall B Levy SB Della-Latta P Larson E Relationship between triclosan and susceptibilities of bacteria isolated from hands in the community Antimicrob Agents Chemother 2004 48 2973 2979 15273108 10.1128/AAC.48.8.2973-2979.2004
Gilbert P McBain A Sreenivasan P Common therapeutic approaches for the control of oral biofilms: microbiological safety and efficacy Clin Microbiol Infect 2007 13 17 24 17716292 10.1111/j.1469-0691.2007.01800.x
Orvos DR Versteeg DJ Inauen J Capdevielle M Rothenstein A Cunningham V Aquatic toxicity of triclosan Environ Toxicol Chem 2002 21 1338 1349 12109732 10.1897/1551-5028(2002)021 2.0.CO;2
Federle TW Kaiser SK Nuck BA Fate and effects of triclosan in activated sludge Environ Toxicol Chem 2002 21 1330 1337 12109731 10.1897/1551-5028(2002)021 2.0.CO;2
Aranami K Readman JW Photolytic degradation of triclosan in freshwater and seawater Chemosphere 2007 66 1052 1056 16930676 10.1016/j.chemosphere.2006.07.010
Keating DH Carey MR Cronan JE Jr The unmodified (apo) form of Escherichia coli acyl carrier protein is a potent inhibitor of cell growth J Biol Chem 1995 270 22229 22235 7673201 10.1074/jbc.270.38.22229
Subrahmanyam S Cronan JE Jr Overproduction of a functional fatty acid biosynthetic enzyme blocks fatty acid synthesis in Escherichia coli J Bacteriol 1998 180 4596 4602 9721301
Heath RJ Li J Roland GE Rock CO Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene J Biol Chem 2000 275 4654 4659 10671494 10.1074/jbc.275.7.4654
McMurry LM McDermott PF Levy SB Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan Antimicrob Agents Chemother 1999 43 711 713 10049298
Heerding DA Chan G DeWolf WE Fosberry AP Janson CA Jaworski DD McManus E Miller WH Moore TD Payne DJ 1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI) Bioorg Med Chem Lett 2001 11 2061 2065 11514139 10.1016/S0960-894X(01)00404-8
Lu H Tonge PJ Inhibitors of FabI, an Enzyme Drug Target in the Bacterial Fatty Acid Biosynthesis Pathway Acc Chem Res 2008 41 11 20 18193820 10.1021/ar700156e
Heath RJ Rock CO A triclosan-resistant bacterial enzyme Nature 2000 406 145 146 10910344 10.1038/35022656
Marrakchi H Dewolf WE Jr Quinn C West J Polizzi BJ So CY Holmes DJ Reed SL Heath RJ Payne DJ Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK) Biochem J 2003 370 1055 1062 12487627 10.1042/BJ20021699
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.